Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene (ENSG00000226750) is annotated as a **pseudogene** that has sequence similarity to part of the ERCC3 gene ("excision repair cross-complementing rodent repair deficiency, complementation group 3"), also known as XPB. Unlike the functional ERCC3 gene, which encodes a DNA helicase essential for nucleotide excision repair and regulation of transcription, this pseudogene does not encode a functional protein and is not considered a therapeutic target[5][6]. Pseudogenes may arise from gene duplication or retrotransposition events but lack coding potential and are generally not involved in disease or drug interaction. There is no evidence of a functional role, disease mechanism, or utility as a therapeutic target for ENSG00000226750. **Summary:** ENSG00000226750 is a pseudogene, not a protein-coding gene or functional receptor/enzyme/target. Information on canonical ERCC3 is not directly applicable to this entry, and it should not be considered a drug target or biomarker[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of excision repair cross-complementing rodent repair deficiency, complementation group 3.